Pollheimer Marion J, Hinterleitner Thomas A, Pollheimer Verena S, Schlemmer Andrea, Langner Cord
Institute of Pathology, Medical University, Auenbruggerplatz, Graz, Austria.
BJU Int. 2008 Aug;102(3):315-9. doi: 10.1111/j.1464-410X.2008.07617.x. Epub 2008 Mar 11.
To investigate the incidence, clinical presentation and therapy of gastric metastases, an uncommon finding, in a large group of patients with renal cell carcinoma (RCC).
We systematically searched the computerized RCC database of our institute, covering 2082 patients (1180 men and 902 women) who had surgery between January 1984 and September 2005, to identify those with a synchronous and/or metachronous diagnosis of cancer in gastric biopsies or resection specimens. The histopathological slides of both renal and gastric cancer probes, and the clinical presentation, treatment and outcome of affected patients, were reassessed.
Twelve patients with primary gastric cancer, one with local RCC recurrence affecting the antrum and five with clear cell RCC (three men and two women; mean age 73 years, range 65-83) with haematogenous cancer spread to the stomach were detected. The mean (range) time to gastric metastasis was 6.9 (1.7-13.1) years. There were metastases to other organs, most often the lung, in all patients. Three patients presented with symptoms of gastrointestinal bleeding, which was successfully controlled by local endoscopic therapy. Four patients died from disease at 3-19 months after diagnosis. One patient is still alive with disease after approximately 2 years.
Gastric metastasis in patients with RCC appears to be a late event in the course of the disease. Most patients show concomitant tumour spread to other organs, and the outcome is generally poor. The use of targeted drugs might offer a new perspective for affected patients.
在一大群肾细胞癌(RCC)患者中,研究胃转移这一罕见情况的发生率、临床表现及治疗方法。
我们系统检索了本研究所的RCC计算机数据库,该数据库涵盖了1984年1月至2005年9月期间接受手术的2082例患者(1180例男性和902例女性),以确定那些在胃活检或切除标本中存在同步和/或异时性癌症诊断的患者。对肾癌和胃癌样本的组织病理学切片以及受影响患者的临床表现、治疗和结局进行了重新评估。
检测到12例原发性胃癌患者、1例局部RCC复发累及胃窦的患者以及5例透明细胞RCC患者(3例男性和2例女性;平均年龄73岁,范围65 - 83岁),这些患者均发生血行性癌转移至胃。发生胃转移的平均(范围)时间为6.9(1.7 - 13.1)年。所有患者均有转移至其他器官的情况,最常见的是肺。3例患者出现胃肠道出血症状,通过局部内镜治疗成功控制。4例患者在诊断后3 - 19个月死于疾病。1例患者在大约2年后仍患有疾病存活。
RCC患者发生胃转移似乎是疾病过程中的晚期事件。大多数患者伴有肿瘤扩散至其他器官,且总体预后较差。靶向药物的使用可能为受影响患者提供新的治疗前景。